FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, particularly to pharmaceutical industry. There is specified a percentage of the components representing a combination of active ingredients: chondroitin sulphate, glycosamine sulphate, troxerutin, methyl sulfonyl methane, N-methyl-2-pyrrolidone, adjuvants: sodium metabisulfite, methyl parahydroxybenzoate, propylene glycol, ethanol, carbomer, aromatizer and purified waters in certain amount for treating joint diseases.
EFFECT: use of the declared composition in each version allows to accelerate penetration of active ingredients into a joint region and to intensify their action on a joint inflammation and pain source.
5 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
| COMPOSITION POSSESSING ANALGESIC, ANTI-INFLAMMATORY AND LOCOMOTOR FUNCTION IMPROVING ACTION | 2011 |
|
RU2468805C2 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
| AGENT FOR CARE OF PERIPHERAL JOINTS AND BACKBONE AREA | 2008 |
|
RU2376011C1 |
| COMBINED SOFT DOSAGE FORM OF DIOSMIN AND TROXERUTIN | 2018 |
|
RU2689409C1 |
| STABILISED PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES CAUSED BY VENOUS INSUFFICIENCY | 2011 |
|
RU2458694C1 |
